George Migausky

Mr. George V.
Migausky is an Independent Director at REGENXBIO, Inc. He is on the Board of Directors at REGENXBIO, Inc., Immunovant Sciences Ltd. and Massachusetts Eye & Ear Infirmary, Inc. Mr. Migausky was previously employed as an Independent Director by Abeona Therapeutics, Inc., an Independent Director by Immunovant, Inc., a Chief Financial Officer by Ocular Therapeutix, Inc., an Independent Director by Dimension Therapeutics, Inc., a Chief Financial Officer & Executive Vice President by Dyax Corp., an Independent Director by Hyperion Catalysis International, Inc., a Chief Financial Officer by Wellstat Management Co. LLC, a Chief Financial Officer & Vice President by BioVeris Corp., a Chief Financial Officer & Vice President by IGEN International, Inc., and a Manager by Deloitte & Touche.
He also served on the board at Health Sciences Acquisitions Corp., Immunovant, Inc. /Old/ and Rocket Pharmaceuticals, Inc. He received his undergraduate degree from Boston College and an MBA from Babson College.